CHF welcomed the Review of Medicines and Medical Device Regulation and, while we did not support removing the required pre-approval of therapeutic goods advertisements, we are pleased to work with the Therapeutic Goods Administration (TGA) to ensure that new arrangements will continue to protect...Read more
About Policy Submissions
We regularly make submissions to national level inquiries. If you are after a submission from earlier than listed here, please contact us.
CHF has consistently advocated123 for a national, whole-of-society obesity strategy. This is because recent reports show that years of public education campaigns have failed to reverse the rise in obesity, showing that it is well past time for individual-oriented prevention to become a priority...Read more
CHF works to achieve safe, quality, timely and affordable healthcare for all Australians, supported by accessible health information and systems. We support the principles of consumer centred care and chief among these is the principle of universal health care1. Private Health Insurance (PHI)...Read more
At the heart of CHF’s policy agenda is patient-centred care. Our responses to the public consultation have been formed with a patient-centred approach in mind. CHF is a strong advocate of the development of guidelines for all sectors of the health system. While guidelines are only...Read more
CHF believe all Australians, no matter their location, should have access to safe, good quality and timely health care. Rates of mental health conditions and suicide are much higher in rural and remote areas. Yet, unfortunately we find the mental health workforce unevenly distributed across...Read more
CHF appreciates the opportunity to provide a submission in response to the Australian Commission on Safety and Quality in Health Care (ACSQHC) on Patient Safety and Quality Improvement in Primary Care Consultation Paper. At the heart of CHF’s policy agenda is patient-centred care. Our responses...Read more
Presenting options for regulatory reforms to make a positive contribution to reducing the misuse and abuse of strong opioids and contributing to better pain management for consumers. Read more
This workshop was the last scheduled opportunity for stakeholders to provide feedback before the Department of Health releases the final document to the public. We appreciate being able to submit this follow-up letter to provide more detail on some of the statements we made at the workshop and...Read more
CHF is pleased to make a submission to the consultation on early release of superannuation benefits under compassionate and financial hardship grounds and for victims of crime compensation. CHF’s interest in this issue is related to ensuring Australians have affordable access to the health...Read more
We welcome the opportunity to make this submission in response to the consultation paper on proposed regulatory changes related to personalised and 3D printed medical devices released by the Therapeutic Goods Administration (TGA) in November 2017.
New manufacturing technologies present...Read more